Bruin Biometrics Transitions Sales of Provizio SEM Scanner
Today marks an important development as Bruin Biometrics and Arjo announce the shift of direct sales and marketing responsibilities for the Provizio SEM Scanner from Arjo to Bruin Biometrics. This transition comes after four years of productive collaboration between the companies, aiming to streamline customer support and enhance service delivery.
Focus on Customer Support and Innovation
Following this agreement, Bruin Biometrics is committed to maintaining a high level of service for all users of the Provizio SEM Scanner. Both companies are dedicated to ensuring that customers transition smoothly while receiving the necessary support during this change. The decision not to extend the original distribution agreement reflects a strategic evolution aimed at improving focus and resources on service and innovation.
Commitment from Both Companies
Bruin Biometrics' CEO, Martin Burns, expressed the company's dedication, stating, "Supporting Provizio SEM Scanner users' work to achieve a zero incidence of preventable pressure injuries in all care settings is our top priority." This commitment is vital in a healthcare landscape increasingly focused on prevention and efficient management of pressure injuries.
Arjo's President and CEO, Joacim Lindoff, highlighted the broader implications of this focus on pressure injuries. He noted that such injuries pose significant economic challenges to healthcare systems worldwide. With their extensive experience in solutions to prevent and treat these conditions, Arjo is looking forward to supporting their customers through this transition.
Understanding the Provizio SEM Scanner
The Provizio SEM Scanner stands out as an advanced tool in the detection and prevention of pressure injuries. Utilizing innovative technology, it aids healthcare professionals in identifying patients at risk of developing these conditions. The scanner has been recognized for its contributions to improving patient outcomes, thus enhancing the overall quality of care. This marks a key step towards reducing pressure injuries across various healthcare settings, ensuring better patient management.
Strategic Next Steps
Transitioning the sales and marketing responsibilities allows Bruin Biometrics to focus on expanding its market reach and enhancing user engagement with the Provizio SEM Scanner. As the healthcare landscape evolves, staying ahead of technological advancements becomes crucial. With a shared goal to improve patient outcomes and reduce economic burdens associated with pressure injuries, both companies aim to position themselves as leaders in this vital area of patient care.
About Bruin Biometrics
Bruin Biometrics LLC is dedicated to advancing healthcare through innovative biometric sensor technology. Their work on SEM Assessment Technology has garnered multiple awards, showcasing their commitment to enhancing the detection and monitoring of chronic health conditions. With a focus on supporting healthcare providers, Bruin Biometrics seeks to integrate their technology within diverse care settings, ensuring a positive impact on patient health.
Frequently Asked Questions
What is the Provizio SEM Scanner?
The Provizio SEM Scanner is a tool designed to help healthcare professionals detect and prevent pressure injuries in patients.
Why did Arjo transition sales of the scanner to Bruin Biometrics?
The transition aims to streamline operations and enhance customer support while allowing Arjo to focus on other solutions.
How does Bruin Biometrics plan to support current users of the scanner?
Bruin Biometrics is committed to providing high-quality customer service and support to all Provizio SEM Scanner users during this transition.
What are pressure injuries and why are they significant?
Pressure injuries, also known as pressure ulcers, are serious skin and tissue injuries that can occur in patients with limited mobility, representing a major healthcare challenge.
How does SEM Assessment Technology work?
SEM Assessment Technology uses biometric sensors to assess and monitor the risk of pressure injuries, aiding healthcare professionals in early detection and intervention.
